Eldisine
Eldisine is a medicine authorised by Swissmedic under authorisation number 42863. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 March 1982 and the authorisation is valid without a time limit. ATC code L01CA03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 42863 |
|---|---|
| Name | Eldisine |
| Full name | Eldisine, Pulver zur Herstellung einer Injektionslösung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01CA03 |
| First authorisation | 16 March 1982 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Eldisine, Pulver zur Herstellung einer Injektionslösung | A | 10 June 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 25 | 1 | Durchstechflasche(n) | L01CA03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Eldisine authorised in Switzerland?
Yes. Eldisine is authorised by Swissmedic under authorisation number 42863, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Eldisine have?
Eldisine is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Eldisine?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.